Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related Benign Pleural Disease An Observational Pilot Study


YILDIRIM H., METİNTAŞ M., ENTOK E., AK G., AK SİVRİKOZ İ., DÜNDAR E., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.4, no.12, pp.1480-1484, 2009 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 4 Issue: 12
  • Publication Date: 2009
  • Doi Number: 10.1097/jto.0b013e3181c0a7ff
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1480-1484
  • Keywords: F-18-fluorodeoxyglucose positron emission tomography-computed, tomography, Asbestos, Pleural disease, Malignant mesothelioma, Diffuse pleural thickening, Benign asbestos-related pleural effusions, PET, CT, DIAGNOSIS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background: Several studies have already addressed the potential role of an increased fluorine 18 fluorodeoxyglucose (F-18 FDG) uptake in identification of pleural malignancy. In this pilot study, we investigate the role of F-18-FDG positron emission tomography/computed tomography (PET/CT) for differentiating asbestos-related benign pleural disease from malignant mesothelioma.